Department of Scientific Research Project, Affiliated Zhongshan Hospital of Dalian University, Dalian, China
Department of Clinical Nutrition and Metabolism, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
BMJ Open. 2019 Nov 21;9(11):e031803. doi: 10.1136/bmjopen-2019-031803.
Hyperuricemia and obesity both play a role in the development of hypertension. However, limited evidence is available for the combined effect of hyperuricemia and obesity on the prevalence of hypertension in the Chinese population. We aimed to assess the separate and combined effects of these two risk factors on the risk of hypertension.
We conducted a cross-sectional study in an area of Dalian city, Liaoning Province, China, from September 2015 to November 2016; 8700 adult residents were invited to participate in this study. Hyperuricemia was defined as serum uric acid ≥ 416 μmol/L in men and ≥ 357 μmol/L in women according to the guidelines. Individuals were categorised into four groups: the control group (body mass index (BMI) §amp;lt; 25 without hyperuricemia, the reference group), the obesity group (BMI ≥ 25 without hyperuricemia), the hyperuricemia group (BMI §amp;lt; 25 with hyperuricemia) and the obese-hyperuricemia group (BMI ≥ 25 with hyperuricemia). A multivariable logistic model was used to investigate individual and combined effects of hyperuricemia and obesity on the risk of hypertension.
Of the 8331 individuals included, 44.3% were obese, 13.6% suffered from hyperuricemia, and 7.8% were both obese and hyperuricemic. The hypertension prevalence was the highest in the obese-hyperuricemia group (55.5% (95% CI 51.6% to 59.2%)), followed by that in the obesity (44.3% (42.6% to 46.1%)) and that in the hyperuricemia groups (33.5% (29.5% to 37.9%)). After adjusting for confounders, the obese-hyperuricemia group had a nearly threefold increased risk of hypertension compared with their healthy counterparts (OR 2.98 (2.48 to 3.57)). This pattern was also observed in the obesity group with a higher risk of hypertension (OR 2.18 (1.96 to 2.42)) compared with the control group, whereas the risk of hypertension was not elevated significantly in the hyperuricemia group (OR 1.14 (0.92 to 1.42)).
Our study provided the first evidence that obese Chinese individuals with hyperuricemia had a significantly increased risk of hypertension compared with their healthy counterparts. This combined effect on the risk of hypertension is much stronger than the individual effect of either factor.
高尿酸血症和肥胖均与高血压的发生有关。然而,在中国人群中,关于高尿酸血症和肥胖合并对高血压患病率的影响,目前仅有有限的证据。本研究旨在评估这两个危险因素分别和合并对高血压风险的影响。
本研究为横断面研究,于 2015 年 9 月至 2016 年 11 月在辽宁省大连市某地区开展,共邀请 8700 名成年居民参与。高尿酸血症定义为男性血清尿酸≥416 μmol/L,女性血清尿酸≥357 μmol/L,符合上述指南标准。根据有无高尿酸血症和体重指数(BMI)将个体分为四组:对照组(BMI<25kg/m²且无高尿酸血症)、肥胖组(BMI≥25kg/m²且无高尿酸血症)、高尿酸血症组(BMI<25kg/m²且有高尿酸血症)和肥胖合并高尿酸血症组(BMI≥25kg/m²且有高尿酸血症)。采用多变量逻辑回归模型探讨高尿酸血症和肥胖对高血压风险的单独和联合作用。
在纳入的 8331 名个体中,44.3%为肥胖,13.6%患有高尿酸血症,7.8%同时患有肥胖症和高尿酸血症。肥胖合并高尿酸血症组的高血压患病率最高(55.5%(95%CI 51.6%至 59.2%)),其次是肥胖组(44.3%(42.6%至 46.1%))和高尿酸血症组(33.5%(29.5%至 37.9%))。校正混杂因素后,与健康对照组相比,肥胖合并高尿酸血症组患高血压的风险增加近三倍(OR 2.98(2.48 至 3.57))。肥胖组与对照组相比,患高血压的风险也显著增加(OR 2.18(1.96 至 2.42)),而高尿酸血症组的高血压风险无显著升高(OR 1.14(0.92 至 1.42))。
本研究首次提供证据表明,与健康对照组相比,中国肥胖合并高尿酸血症的个体患高血压的风险显著增加。这种对高血压风险的联合作用强于单一因素的作用。